ORGANIC
LETTERS
2009
Vol. 11, No. 19
4398-4401
Total Synthesis of Euplectin, a Natural
Product with a Chromone Fused
Indenone
Dipakranjan Mal* and Saroj Ranjan De
Department of Chemistry, Indian Institute of Technology, Kharagpur 721302, India
Received August 6, 2009
ABSTRACT
The first total synthesis of euplectin, a rare metabolite with a chromone annulated indenone motif, has been accomplished in 17 steps. This
has been possible through interplay among three key reactions: a Hauser sulfoxide annulation, a new chromone formation and a late-stage
retro-Diels-Alder reaction. The entire regiochemical integrity of the successful route is established by an iodine-catalyzed aromatization of
a cyclohexane-1,3-dione and the Hauser annulation.
The natural products with annulated chromone nuclei are
an emerging class of metabolites. In recent years, members
like 6-methoxycomapavin 1,1 isonigerone 2,2 and pluramycin
33 (Figure 1) have gained enormous attention due to their
antitumor, antibacterial, and enzyme inhibitory activities. Their
synthetic chemistry has duly been advanced by many research
groups: namely, Dallavalle,4 Danishefsky,5 Hauser,6 Hecht,7
Kozlowski,8 Krohn,9 McDonald,10 Suzuki,11 Tietze,12 and
Uno13 groups. More specifically, 5-hydroxychromones, annu-
(8) Kozlowski, M. C.; Dugan, E. C.; DiVirgilio, E. S.; Maksimenka,
K.; Bringmann, G. AdV. Synth. Catal. 2007, 349, 583–594.
(9) (a) Krohn, K.; Tran-Thien, H. T.; Vitz, J.; Vidal, A. Eur. J. Org.
Chem. 2007, 1905–1911. (b) Krohn, K.; Vidal, A.; Vitz, J.; Westermann,
B.; Abbas, M.; Green, I. Tetrahedron: Asymmetry 2006, 17, 3051–3057.
(10) Fei, Z. B.; McDonald, F. E. Org. Lett. 2007, 9, 3547–3550.
(11) Hsu, D. S.; Matsumoto, T.; Suzuki, K. Chem. Lett. 2006, 35, 1016–
1017.
(1) Folmer, F.; Harrison, W. T. A.; Tabudravu, J. N.; Jaspars, M.;
Alabersberg, W.; Feussner, K.; Wright, A. D.; Dicato, M.; Diederich, M.
J. Nat. Prod. 2008, 71, 106–111.
(12) Tietze, L. F.; Singidi, R. R.; Gericke, K. M.; Boeckemeier, H.;
Laatsch, H. Eur. J. Org. Chem. 2007, 5875–5878.
(13) Uno, H.; Sakamoto, K.; Honda, E.; Ono, N. Chem. Commun. 1999,
1005–1006.
(2) (a) Gorst-Allman, C. P.; Steyn, P. S.; Rabie, C. J. J. Chem. Soc.,
Perkin Trans. 1 1980, 2474–2479. (b) Koyama, K.; Natori, S.; Iitaka, Y.
Chem. Pharm. Bull. 1987, 35, 4049–4055.
(14) Kanai, Y.; Ishiyama, D.; Senda, H.; Iwatani, W.; Takahashi, H.;
Konno, I.; Tokumasu, S.; Kanazawa, S. J. Antibiot. 2000, 53, 863–872.
(15) (a) Arnone, A.; Camarda, L.; Merlini, L.; Nashini, G. Gazz. Chim.
Ital. 1975, 105, 1093–1103. (b) Syrchina, A. I.; Semenov, A. A. Khim.
Prir. Soedin. 1982, 3–14. (c) Kamat, S. P.; Menezes, J. C.; Siddhaye, B. M.;
Paknikar, S. K. Indian J. Chem. 2008, 47B, 1597–1599. (d) Nagle, D. G.;
Zhou, Y.-D.; Park, P. U.; Paul, V. J.; Rajbhandari, I.; Duncan, C. J. G.;
Pasco, D. S. J. Nat. Prod. 2000, 63, 1431–1433. (e) Dai, J.; Krohn, K.;
Floerke, U.; Draeger, S.; Schulz, B.; Kiss-Szikszai, A.; Antus, S.; Kurtan,
T.; van Ree, T. Eur. J. Org. Chem. 2006, 3498–3506.
(3) Nagai, K.; Yamaki, H.; Tanaka, N.; Umezawak, H. J. Biochem. 1967,
62, 321–327.
(4) Dallavalle, S.; Gattinoni, S.; Mazzini, S.; Scaglioni, L.; Merlini, L.;
Tinelli, S.; Beretta, G. L.; Zunino, F. Bioorg. Med. Chem. Lett. 2008, 18,
1484–1489.
(5) Wright, B. J. D.; Hartung, J.; Peng, F.; Water, R. V. D.; Liu, H.;
Tan, Q.; Chou, T.; Danishefsky, S. J. J. Am. Chem. Soc. 2008, 130, 16786–
16790.
(6) Hauser, F. M.; Rhee, R. P. J. Am. Chem. Soc. 1979, 101, 1628–
1629.
(16) Russell, M. A.; Chai, C. L. L.; Wardlaw, J. H.; Elix, J. A. J. Nat.
Prod. 2000, 63, 129–131.
(7) Khan, Q. A.; Elban, M. A.; Hecht, S. M. J. Am. Chem. Soc. 2008,
130, 12888–12889.
(17) Marvel, C. S.; Hinman, C. W. J. Am. Chem. Soc. 1954, 76, 5435–
5437.
10.1021/ol901817r CCC: $40.75
Published on Web 09/08/2009
2009 American Chemical Society